Head and Neck Imaging

Clinical Value of Preoperative MSCT Combined with Serum SCC, CA19-9 and CEA Examination in the Diagnosis of Esophageal Cancer

Author:LAN Cong, LIN Wan-li, CHEN Ying,et al.

affiliation:Department of Thoracic Surgery, People's Hospital of Gaozhou City, Maoming 525200, Guangdong Province, China

PDF

Abstract

Objective To analyze the clinical value of preoperative multislice helice CT (MSCT) combined with serum squamous cell carcinoma (SCC), carbohydrate antigen 19-9 (CA19-9) and carcino-embryonic antigen (CEA) examination in the diagnosis of esophageal cancer. Methods 76 patients with suspected esophageal cancer admitted to the hospital were enrolled. MSCT and serum SCC, CA19-9 and CEA examination were performed before operation. Taking the pathological results as the golden standard, the accuracy, specificity and sensitivity of MSCT and MSCT combined with serum SCC and CA19-9 and CEA examination were compared. Results Pathological examination results showed that there were 68 cases with esophageal cancer and 8 cases without esophageal cancer. The diagnostic sensitivity, specificity, accuracy and the Kappa value of MSCT were 85.29%, 75.00%, 84.21% and 0.42, respectively. The above 4 indexes of MSCT combined with serum SCC, CA19-9 and CEA were 97.06%, 87.50%, 96.05% and 0.80, respectively. The accuracy and sensitivity of MSCT combined with serum SCC, CA19-9 and CEA in the diagnosis of esophageal cancer were significantly higher than those of MSCT (P<0.05). Conclusion Preoperative MSCT combined with serum SCC, CA19-9 and CEA examination can effectively improve the diagnostic sensitivity and accuracy for esophageal cancer, which has relatively higher application value.

【Keyword】Multisliecs Helieal CT; Squamous Cell Carcinoma; Carbohydrate Antigen 19-9; Carcino-embryonic Antigen; Esophageal Cancer

【Chart number】R735.1;R445.3

【Document Identification Number】A

【DOI】 10.3969/j.issn.1672- 5131.2019.05.027